Reject the Misleading Agendas of Musk and Ramaswamy: Combat Corporate Bailouts, Tax the Wealthy, and Invest in the Future
Focusing on the controversy over U.S. government efficiency, analyzing core issues such as price gouging in the pharmaceutical industry and the privatization of healthcare, and proposing evidence-based fiscal optimization and public investment strategies. ()
Detail
Published
23/12/2025
Key Chapter Title List
- Introduction
- The True Face of Efficiency
- Ending Price Gouging in the Pharmaceutical Industry
- Terminating the Privatization of Medicare
- Reducing Pentagon Waste and Curbing Contractor Greed
- Taxing the Wealthy and Corporations
- Taxing High-Income Earners and the Wealthy
- Eliminating Fossil Fuel Industry Subsidies
- Regulatory Efficiency
- The Cost of Deregulation
- Investing in the Care Economy
- Investing to Avert Climate Disaster
Document Overview
In November 2024, U.S. President-elect Donald Trump announced the establishment of the Department of Government Efficiency (DOGE), co-chaired by billionaire Elon Musk and Vivek Ramaswamy, claiming it would cut 2 trillion dollars in government spending, streamline bureaucracy, and deregulate. However, the agency is essentially an advisory body with no direct decision-making authority. Its core agenda is not genuinely improving government efficiency but rather implementing ideologically driven policy rollbacks to benefit corporate interests.
This report directly addresses the impracticality of the DOGE plan—the total U.S. federal discretionary spending is less than 2 trillion dollars, making the proposed cuts unachievable in reality. The report further argues that true government efficiency should not be about pre-set spending reduction targets or weakening regulatory protections. Instead, it should focus on eliminating waste, optimizing resource allocation, raising revenue fairly, and maximizing the economic return on public expenditures.
Based on detailed data and case studies, the report proposes a series of policy interventions that could save the United States hundreds of billions of dollars annually and generate hundreds of billions in additional revenue. These include: saving 200 billion dollars annually on prescription drugs by strengthening government bargaining power and promoting generic competition; saving 100 billion dollars annually and improving healthcare quality by ending the privatization of Medicare; saving 100 to 200 billion dollars annually through moderate cuts to the Pentagon budget; saving approximately 20 billion dollars annually by eliminating fossil fuel industry subsidies; and generating 500 billion dollars in new annual revenue by imposing fair taxes on the wealthy and corporations.
The report also systematically demonstrates the economic value of regulation, pointing out that major regulatory measures generate positive economic returns, while deregulation has led to catastrophic consequences such as the 2008 financial crisis, resulting in trillions of dollars in economic losses. Furthermore, the report emphasizes the high efficiency of investments in social areas like early childhood education, healthcare, and nutritional support, as well as the critical importance of public investment in combating climate change for protecting economic security. These investments not only yield significant economic returns but also produce broad social and environmental benefits.
This report provides policymakers and researchers with an evidence-based policy framework, exposes the potential harms of ideologically driven agendas carried out in the name of efficiency, and offers an important reference for building a fair, efficient, and sustainable public policy system.